Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
39.96
-2.76 (-6.46%)
Mar 31, 2025, 10:58 AM EDT - Market open
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $3.18 billion as of March 31, 2025. Its market cap has increased by 64.98% in one year.
Market Cap
3.18B
Enterprise Value
2.64B
1-Year Change
64.98%
Ranking
Category
Stock Price
$39.96
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $3.18B, an increase of 542.15%. That is a compound annual growth rate of 37.99%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |